Besides, in ALI model mice, intratracheal administration of ZPM@PDE-siZEB1/2 could simultaneously deliver siZEB1 and siZEB2 into the inflammatory lung and effectively silence ZEB1/2, thereby delaying the progression of LPS-induced early pulmonary fibrosis in ALI mice. Here, ZEB1 is linked to pulmonary fibrosis.